In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agentsPFALLER, M. A; MESSER, S. A; COFFMAN, S et al.Antimicrobial agents and chemotherapy. 1997, Vol 41, Num 4, pp 763-766, issn 0066-4804Article

Clinical evaluation of a dried commercially-prepared microdilution panel for antifungal susceptibility testingMESSER, S. A; PFALLER, M. A.Diagnostic microbiology and infectious disease. 1996, Vol 25, Num 2, pp 77-81, issn 0732-8893Article

Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870PFALLER, M. A; MESSER, S. A; COFFMANN, S et al.Journal of clinical microbiology (Print). 1995, Vol 33, Num 5, pp 1094-1097, issn 0095-1137Article

Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin BPFALLER, M. A; MESSER, S. A; BOLMSTRÖM, A et al.Diagnostic microbiology and infectious disease. 1998, Vol 32, Num 3, pp 223-227, issn 0732-8893Article

Validation of 24-Hour Posaconazole and Voriconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Application of Epidemiological Cutoff Values to Results from a Global Candida Antifungal Surveillance ProgramPFALLER, M. A; BOYKEN, L. B; HOLLIS, R. J et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 4, pp 1274-1279, issn 0095-1137, 6 p.Article

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida sppPFALLER, M. A; BOYKEN, L; HOLLIS, R. J et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 1, pp 52-56, issn 0095-1137, 5 p.Article

Clinical Evaluation of the Sensititre YeastOne Colorimetric Antifungal Panel for Antifungal Susceptibility Testing of the Echinocandins Anidulafungin, Caspofungin, and MicafunginPFALLER, M. A; CHATURVEDI, V; DIEKEMA, D. J et al.Journal of clinical microbiology (Print). 2008, Vol 46, Num 7, pp 2155-2159, issn 0095-1137, 5 p.Article

Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 Clinical isolates of Cryptococcus neoformansMAXWELL, M. J; MESSER, S. A; HOLLIS, R. J et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 1, pp 97-99, issn 0095-1137, 3 p.Article

In Vitro Susceptibility Testing of Filamentous Fungi: Comparison of Etest and Reference M38-A Microdilution Methods for Determining Posaconazole MICsPFALLER, M. A; MESSER, S. A; BOYKEN, L et al.Diagnostic microbiology and infectious disease. 2003, Vol 45, Num 4, pp 241-244, issn 0732-8893, 4 p.Article

Molecular epidemiology of Gram-negative bacteremiaWENDT, C; MESSER, S. A; HOLLIS, R. J et al.Clinical infectious diseases. 1999, Vol 28, Num 3, pp 605-610, issn 1058-4838Conference Paper

Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testingPFALLER, M. A; ARIKAN, S; WANG, J et al.Journal of clinical microbiology (Print). 1998, Vol 36, Num 9, pp 2609-2612, issn 0095-1137Article

International surveillance of bloodstream infections due to Candida species : Frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRE ProgramPFALLER, M. A; JONES, R. N; DOERN, G. V et al.Journal of clinical microbiology (Print). 1998, Vol 36, Num 7, pp 1886-1889, issn 0095-1137Article

National surveillance of nosocomial blood stream infection due to Candida albicans : Frequency of occurrence and antifungal susceptibility in the scope programPFALLER, M. A; JONES, R. N; MESSER, S. A et al.Diagnostic microbiology and infectious disease. 1998, Vol 31, Num 1, pp 327-332, issn 0732-8893Article

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans : Frequency of occurrence and antifungal susceptibility in the scope programPFALLER, M. A; JONES, R. N; MESSER, S. A et al.Diagnostic microbiology and infectious disease. 1998, Vol 30, Num 2, pp 121-129, issn 0732-8893Article

Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungiMARCO, F; PFALLER, M. A; MESSER, S. A et al.Medical mycology (Oxford. Print). 1998, Vol 36, Num 6, pp 433-436, issn 1369-3786Article

Candida albicans arthritis one year after successful treatment of fungemia in a healthy infantSWANSON, H; HUGHES, P. A; MESSER, S. A et al.The Journal of pediatrics. 1996, Vol 129, Num 5, pp 688-694, issn 0022-3476Article

Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff valuesPFALLER, M. A; CHATURVEDI, V; DIEKEMA, D. J et al.Diagnostic microbiology and infectious disease. 2012, Vol 73, Num 4, pp 365-368, issn 0732-8893, 4 p.Article

Comparison of the Broth Microdilution (BMD) Method of the European Committee on Antimicrobial Susceptibility Testing with the 24-Hour CLSI BMD Method for Testing Susceptibility of Candida Species to Fluconazole, Posaconazole, and Voriconazole by Use of Epidemiological Cutoff ValuesPFALLER, M. A; ESPINEL-INGROFF, A; BOYKEN, L et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 3, pp 845-850, issn 0095-1137, 6 p.Article

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin : Six Years of Global SurveillancePFALLER, M. A; BOYKEN, L; HOLLIS, R. J et al.Journal of clinical microbiology (Print). 2008, Vol 46, Num 1, pp 150-156, issn 0095-1137, 7 p.Article

Validation of 24-Hour Fluconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method : Results from a Global Candida Antifungal Surveillance Program∇PFALLER, M. A; BOYKEN, L. B; HOLLIS, R. J et al.Journal of clinical microbiology (Print). 2008, Vol 46, Num 11, pp 3585-3590, issn 0095-1137, 6 p.Article

Global surveillance of in vitro activity of micafungin against Candida : A comparison with caspofungin by CLSI-recommended methodsPFALLER, M. A; BOYKEN, L; HOLLIS, R. J et al.Journal of clinical microbiology (Print). 2006, Vol 44, Num 10, pp 3533-3538, issn 0095-1137, 6 p.Article

In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agentsPFALLER, M. A; DIEKEMA, D. J; MESSER, S. A et al.Diagnostic microbiology and infectious disease. 2004, Vol 48, Num 2, pp 101-105, issn 0732-8893, 5 p.Article

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungiDIEKEMA, D. J; MESSER, S. A; HOLLIS, R. J et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 8, pp 3623-3626, issn 0095-1137, 4 p.Article

Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformansYAMAZUMI, T; PFALLER, M. A; MESSER, S. A et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 1, pp 267-272, issn 0095-1137, 6 p.Article

Epidemiology of candidemia: 3-Year results from the emerging infections and the epidemiology of Iowa organisms studyDIEKEMA, D. J; MESSER, S. A; BRUEGGEMANN, A. B et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 4, pp 1298-1302, issn 0095-1137Article